Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo

Molecular Oncology

Volumn 5, Issue 6, 2011, Pages 527-537

  Conrotto, Paolo ^a   Andréasson, Ulrika ^a   Kuci, Venera ^a   Borrebaeck, Carl A K ^a   Ek, Sara ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Autotaxin; MCL; NOD SCID mice; Proliferation; SOX11; Z138

Indexed keywords

AUTOTAXIN; LYSOPHOSPHOLIPASE; LYSOPHOSPHOLIPASE D; TRANSCRIPTION FACTOR SOX11; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

MUS;

EID: 80053575683     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2011.08.001     Document Type: Article

References (40)

1. Amin H.M., McDonnell T.J., Medeiros L.J., Rassidakis G.Z., Leventaki V., O'Connor S.L., Keating M.J., Lai R. Characterization of 4 mantle cell lymphoma cell lines. Arch. Pathol. Lab. Med. 2003, 127:424-431.
2. Braddock D.T. Autotaxin and lipid signaling pathways as anticancer targets. Curr. Opin. Investig. Drugs 2010, 11:629-637.
3. Chen Y.H., Gao J., Fan G., Peterson L.C. Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms. Mod. Pathol. 2009, 23:105-112.
4. Clair T., Aoki J., Koh E., Bandle R.W., Nam S.W., Ptaszynska M.M., Mills G.B., Schiffmann E., Liotta L.A., Stracke M.L. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res. 2003, 63:5446-5453.
5. Dictor M., Ek S., Sundberg M., Warenholt J., Gyorgy C., Sernbo S., Gustavsson E., Abu-Alsoud W., Wadstrom T., Borrebaeck C. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica 2009, 94:1563-1568.
6. Ehrengruber M.U., Kato A., Inokuchi K., Hennou S. Homer/Vesl proteins and their roles in CNS neurons. Mol. Neurobiol. 2004, 29:213-227.
7. Ek S., Hogerkorp C.M., Dictor M., Ehinger M., Borrebaeck C.A. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. Cancer Res. 2002, 62:4398-4405.
8. Ek S., Andreasson U., Hober S., Kampf C., Ponten F., Uhlen M., Merz H., Borrebaeck C.A. From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. Mol. Cell Proteomics 2006, 5:1072-1081.
9. Ek S., Dictor M., Jerkeman M., Jirstrom K., Borrebaeck C.A. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood 2008, 111:800-805.
10. Federico L., Pamuklar Z., Smyth S.S., Morris A.J. Therapeutic potential of autotaxin/lysophospholipase d inhibitors. Curr. Drug Targets 2008, 9:698-708.
11. Fernandez V., Salamero O., Espinet B., Sole F., Royo C., Navarro A., Camacho F., Bea S., Hartmann E., Amador V., Hernandez L., Agostinelli C., Sargent R.L., Rozman M., Aymerich M., Colomer D., Villamor N., Swerdlow S.H., Pileri S.A., Bosch F., Piris M.A., Montserrat E., Ott G., Rosenwald A., Lopez-Guillermo A., Jares P., Serrano S., Campo E. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010, 70:1408-1418.
12. Ferry G., Moulharat N., Pradere J.P., Desos P., Try A., Genton A., Giganti A., Beucher-Gaudin M., Lonchampt M., Bertrand M., Saulnier-Blache J.S., Tucker G.C., Cordi A., Boutin J.A. S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool. J. Pharmacol. Exp. Ther. 2008, 327:809-819.
13. Gill S., Herbert K.E., Prince H.M., Wolf M.M., Wirth A., Ryan G., Carney D.A., Ritchie D.S., Davies J.M., Seymour J.F. Mantle cell lymphoma with central nervous system involvement: frequency and clinical features. Br. J. Haematol. 2009, 147:83-88.
14. Gustavsson E., Sernbo S., Andersson E., Brennan D.J., Dictor M., Jerkeman M., Borrebaeck C.A., Ek S. SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol. Cancer 2010, 9:187.
15. Inoue M., Xie W., Matsushita Y., Chun J., Aoki J., Ueda H. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience 2008, 152:296-298.
16. Klier M., Anastasov N., Hermann A., Meindl T., Angermeier D., Raffeld M., Fend F., Quintanilla-Martinez L. Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2. Leukemia 2008, 22:2097-2105.
17. Kobayashi T., Murakami-Murofushi K. Bioactions and synthesis of a novel lipid mediator, cyclic phosphatidic acid. World Rev. Nutr. Diet. 2001, 88:228-232.
18. Kojima N., Shirao T. Synaptic dysfunction and disruption of postsynaptic drebrin-actin complex: a study of neurological disorders accompanied by cognitive deficits. Neurosci. Res. 2007, 58:1-5.
19. Kuhlbrodt K., Herbarth B., Sock E., Enderich J., Hermans-Borgmeyer I., Wegner M. Cooperative function of POU proteins and SOX proteins in glial cells. J. Biol. Chem. 1998, 273:16050-16057.
20. Liu S., Umezu-Goto M., Murph M., Lu Y., Liu W., Zhang F., Yu S., Stephens L.C., Cui X., Murrow G., Coombes K., Muller W., Hung M.C., Perou C.M., Lee A.V., Fang X., Mills G.B. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 2009, 15:539-550.
21. Masuda A., Nakamura K., Izutsu K., Igarashi K., Ohkawa R., Jona M., Higashi K., Yokota H., Okudaira S., Kishimoto T., Watanabe T., Koike Y., Ikeda H., Kozai Y., Kurokawa M., Aoki J., Yatomi Y. Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br. J. Haematol. 2008, 143:60-70.
22. Medeiros L.J., Estrov Z., Rassidakis G.Z. Z-138 cell line was derived from a patient with blastoid variant mantle cell lymphoma. Leuk. Res. 2006, 30:497-501.
23. Mozos A., Royo C., Hartmann E., De Jong D., Baro C., Valera A., Fu K., Weisenburger D.D., Delabie J., Chuang S.S., Jaffe E.S., Ruiz-Marcellan C., Dave S., Rimsza L., Braziel R., Gascoyne R.D., Sole F., Lopez-Guillermo A., Colomer D., Staudt L.M., Rosenwald A., Ott G., Jares P., Campo E. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 2009, 94:1555-1562.
24. Munger C.M., Vose J.M., Joshi S.S. Dendritic cell-based therapy for mantle cell lymphoma. Int. J. Oncol. 2006, 28:1337-1343.
25. Ngo V.N., Davis R.E., Lamy L., Yu X., Zhao H., Lenz G., Lam L.T., Dave S., Yang L., Powell J., Staudt L.M. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 2006, 441:106-110.
26. Obrador-Hevia A., Fernandez de Mattos S., Villalonga P., Rodriguez J. Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies. Blood Rev. 2009, 23:205-216.
27. Ortega-Paino E., Fransson J., Ek S., Borrebaeck C.A. Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference. Blood 2008, 111:1617-1624.
28. Penzo-Mendez A.I. Critical roles for SoxC transcription factors in development and cancer. Int. J. Biochem. Cell Biol. 2010, 42:425-428.
29. Samadi N., Bekele R., Capatos D., Venkatraman G., Sariahmetoglu M., Brindley D.N. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. Biochimie 2011, 93:61-70.
30. Schafer M.K., Altevogt P. L1CAM malfunction in the nervous system and human carcinomas. Cell Mol. Life Sci. 2010, 67:2425-2437.
31. Tania M., Khan A., Zhang H., Li J., Song Y. Autotaxin: a protein with two faces. Biochem. Biophys. Res. Commun. 2010, 401:493-497.
32. Tucker C.A., Bebb G., Klasa R.J., Chhanabhai M., Lestou V., Horsman D.E., Gascoyne R.D., Wiestner A., Masin D., Bally M., Williams M.E. Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of mantle cell lymphoma. Leuk. Res. 2006, 30:449-457.
33. Umezu-Goto M., Kishi Y., Taira A., Hama K., Dohmae N., Takio K., Yamori T., Mills G.B., Inoue K., Aoki J., Arai H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 2002, 158:227-233.
34. Valdez R., Kroft S.H., Ross C.W., Schnitzer B., Singleton T.P., Peterson L.C., Finn W.G. Cerebrospinal fluid involvement in mantle cell lymphoma. Mod. Patho. 2002, 15:1073-1079.
35. van Meeteren L.A., Moolenaar W.H. Regulation and biological activities of the autotaxin-LPA axis. Prog. Lipid. Res. 2007, 46:145-160.
36. Wang M., Zhang L., Han X., Yang J., Qian J., Hong S., Samaniego F., Romaguera J., Yi Q. Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways. Blood 2007, 109:5455-5462.
37. Wang X., Asplund A.C., Porwit A., Flygare J., Smith C.I., Christensson B., Sander B. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br. J. Haematol. 2008, 143:248-252.
38. Wang X., Bjorklund S., Wasik A.M., Grandien A., Andersson P., Kimby E., Dahlman-Wright K., Zhao C., Christensson B., Sander B. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma. PLoS One 2010, 5:e14085.
39. Wiebe M.S., Nowling T.K., Rizzino A. Identification of novel domains within Sox-2 and Sox-11 involved in autoinhibition of DNA binding and partnership specificity. J. Biol. Chem. 2003, 278:17901-17911.
40. Zhuang B., Su Y.S., Sockanathan S. FARP1 promotes the dendritic growth of spinal motor neuron subtypes through transmembrane Semaphorin6A and PlexinA4 signaling. Neuron 2009, 61:359-372.